Please use this identifier to cite or link to this item:
http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26210
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bukach, O. | - |
dc.contributor.author | Zrybnieva, K. | - |
dc.contributor.author | Kuzemko, I. | - |
dc.contributor.author | Popovych, A. | - |
dc.date.accessioned | 2025-02-21T07:53:51Z | - |
dc.date.available | 2025-02-21T07:53:51Z | - |
dc.date.issued | 2023 | - |
dc.identifier.uri | http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26210 | - |
dc.description.abstract | Abstract. Among the factors that influence the occurrence of rheumatoid arthritis, a complex interaction of genetic, environmental, immunological, hormonal, socio-economic and psychological prerequisites is noted. Genetic factors in interaction with the environment and an individual's lifestyle play an important role in changing gene expression and the clinical realization of inherited or acquired pathology, including multifactorial. That is why the study of genetic mutations and their association in patients with rheumatoid arthritis is important today not only from a scientific point of view, but also for practical health care. | uk_UA |
dc.language.iso | en | uk_UA |
dc.publisher | Slovak international scientific journal | uk_UA |
dc.subject | rheumatoid arthritis | uk_UA |
dc.subject | eNOS gene promoter T-786C polymorphism | uk_UA |
dc.subject | disease-modifying therapy | uk_UA |
dc.subject | cytokine profile | uk_UA |
dc.title | Disease-modifying therapy in rheumatoid arthritis and changes in cytokine levels depending on genetic characteristics | uk_UA |
dc.type | Article | uk_UA |
Appears in Collections: | Статті |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Bukach O. et al. Disease-modifying_57-59_2023.pdf | 154.03 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.